ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+81.91%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$3.4B
AUM Growth
+$3.4B
(+42%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
73.62%
Holding
39
New
5
Increased
9
Reduced
11
Closed
9
Top Buys
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$172M |
| 2 |
uniQure
QURE
|
$95.7M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$74.1M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$31.1M |
| 5 |
Cue Biopharma
CUE
|
$29.7M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$142M |
| 2 |
Pacira BioSciences
PCRX
|
$60.9M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$49.1M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$48.5M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$44.1M |
Sector Composition
| 1 | Healthcare | 84.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $518M | 15.22% | 24,500,000 +3,500,000 | +17% | +$74.1M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $496M | 14.57% | 3,850,200 +100,200 | +3% | +$12.9M |
|
3
Ascendis Pharma
ASND
$11.8B
| $259M | 7.62% | 1,865,000 -105,000 | -5% | -$14.6M |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $244M | 7.17% | 8,826,039 -1,775,000 | -17% | -$49.1M |
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $227M | 6.67% | 1,760,000 +82,000 | +5% | +$10.6M |
|
|
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $172M | 5.05% | +3,650,000 | New | +$172M |
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $169M | 4.97% | 2,000,000 -437,100 | -18% | -$37M |
|
8
argenx
ARGX
$43.6B
| $150M | 4.41% | 936,500 +101,500 | +12% | +$16.3M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $145M | 4.25% | 4,000,000 | – | – |
|
|
10
uniQure
QURE
$896M
| $122M | 3.58% | 1,700,000 +1,335,000 | +366% | +$95.7M |
|
11
Karyopharm Therapeutics
KPTI
$61.7M
| $113M | 3.32% | 5,900,000 -150,000 | -2% | -$2.88M |
|
|
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $112M | 3.3% | 1,540,000 -12,700 | -0.8% | -$926K |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $109M | 3.2% | 11,200,000 +100,000 | +0.9% | +$974K |
|
|
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
| $104M | 3.06% | 2,000,000 +125,000 | +7% | +$6.52M |
|
|
ATNX
15
DELISTED
Athenex, Inc. Common Stock
ATNX
| $80.3M | 2.36% | 5,261,437 -628,563 | -11% | -$9.6M |
|
16
Adverum Biotechnologies
ADVM
$64.6M
| $60.5M | 1.78% | 5,250,000 +1,000,000 | +24% | +$11.5M |
|
|
TCDA
17
DELISTED
Tricida, Inc. Common Stock
TCDA
| $58.9M | 1.73% | 1,560,000 -640,000 | -29% | -$24.2M |
|
|
AMRN
18
Amarin Corp
AMRN
$311M
| $40.7M | 1.2% | 1,900,000 -6,620,000 | -78% | -$142M |
|
19
Madrigal Pharmaceuticals
MDGL
$9.76B
| $31.8M | 0.93% | 349,000 -11,000 | -3% | -$1M |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $31.5M | 0.92% | 2,400,000 | – | – |
|
|
DCPH
21
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $31.1M | 0.91% | +500,000 | New | +$31.1M |
|
|
22
Cue Biopharma
CUE
$60M
| $29.7M | 0.87% | +1,870,000 | New | +$29.7M |
|
23
Allogene Therapeutics
ALLO
$251M
| $29.3M | 0.86% | 1,128,594 | – | – |
|
|
BDSI
24
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $19M | 0.56% | 3,000,000 -4,424,867 | -60% | -$28M |
|
|
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $13.4M | 0.39% | +6,200,000 | New | +$13.4M |
|